Literature DB >> 3824412

Menadione causes selective toxicity to periportal regions of the liver lobule.

M Badr, H Yoshihara, F Kauffman, R Thurman.   

Abstract

Infusion of increasing concentrations (0.2-1 mM) of the quinone, menadione, caused step-wise increases in oxygen uptake in perfused livers from fasted rats presumably due to oxygen-dependent redox cycling. Maximal increases in oxygen uptake of about 40 mumol/g/h were observed with 0.8 to 1.0 mM menadione. This increase in oxygen uptake was confined to periportal areas of the liver lobule suggesting that redox cycling due to menadione occurs exclusively in cells localized around the portal triad. After 60 min of infusion of menadione (1 mM), lactate dehydrogenase was released from the liver at rates between 60 to 70 U/g/h. Under these conditions, trypan blue was taken up by virtually all hepatocytes in periportal regions of the liver lobule. In contrast, dye was not taken up by cells in pericentral areas. It is concluded that menadione is selectively toxic to hepatocytes located in oxygen-rich periportal regions of the liver lobule.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3824412     DOI: 10.1016/0378-4274(87)90212-8

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

Review 1.  Superwarfarin poisoning: a significant public health problem.

Authors:  A E Rauch; R Weininger; D Pasquale; P T Burkart; H G Dunn; C Weissman; E Rydzak
Journal:  J Community Health       Date:  1994-02

2.  Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery.

Authors:  J Takata; Y Karube; M Hanada; K Matsunaga; Y Matsushima; T Sendo; R Oishi
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

3.  Vitamin K prodrugs: 1. Synthesis of amino acid esters of menahydroquinone-4 and enzymatic reconversion to an active form.

Authors:  J Takata; Y Karube; M Hanada; K Matsunaga; Y Matsushima; T Sendo; T Aoyama
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.